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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
The objectives of this systematic review are to determine the effectiveness and safety of acupuncture therapy in patients with autism
spectrum disorder. We intend to assess whether acupuncture:
1. is effective in reducing social, communication and behavioural impairments;
2. can improve the quality of life and overall functioning;
3. is associated with any adverse effects.
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B A C K G R O U N D
Description of the condition
Autistic spectrum disorder (ASD) is a developmental disorder of
children characterized by the triad of impairments of social in-
teraction, social communication, and social imagination (Wing
1997). Repetitive and stereotyped behaviour are often associated
with ASD (Wing 1997). The term includes autistic disorder, As-
perger syndrome and pervasive developmental disorder (not oth-
erwise specified). The impairments of ASD have a severe impact
on learning and social functioning which may persist into adult-
hood. Autistic spectrumdisorder has an estimated prevalence from
5 to 63 children per 10,000 , and there is an increasing trend as
higher prevalence rates have been reported from recent studies (
Chakrabarti 2001, Fombonne 1999). More recently, an overall
figure of 116 in 10,000 has been reported (Baird 2006). This is
of great concern to the practicing pediatrician because of an as-
tonishing 556% reported increase in pediatric prevalence between
1991 and 1997, to a prevalence higher than that of spina bifida,
cancer, or Down syndrome (Muhle 2004). No prevalence studies
have ever been performed on adults.
Autism is a behavior syndrome with multiple aetiologies. There
are a few specific genetic conditions that can be associated with
ASD (Folstein 1991). Among of cases unknown etiology, there is
ample evidence for a higher genetic liability to autism in siblings of
probands (those under genetic investigation) than expected from
the population prevalence (Folstein 1991).The identity and num-
ber of genes involved remain unknown (Muhle 2004). The wide
phenotypic variability of the ASDs likely reflects the interaction
of multiple genes within an individual’s genome and the existence
of distinct genes and gene combinations among those affected (
Muhle 2004). Epidemiologic studies indicate that environmental
factors such as toxic exposures, teratogens, perinatal insults, and
prenatal infections such as rubella and cytomegalovirus account
for few cases (Muhle 2004). Immunolgical bases for neurologi-
cal injure leading to ASD has been proposed (Krause 2002). It is
suggested that ASD might result from an interaction between ge-
netic, environmental, and immunological factors, with oxidative
stress as a mechanism linking these risk factors (Chauhan 2006).
Recently, research has focused on the role of synapse structure and
function as central to the development of autism and suggests pos-
sible targets of interventions (Rapin 2008).
Autistic spectrum disorder is heterogeneous with many associ-
ated problems, such as associations with particular genetic dis-
orders [fragile X, single gene disorders (tuberosis sclerosis, un-
treated phenylketonuria, and possibly neurofibrotosis)] (Folstein
1991), epilepsy (themedical conditionmost highly associatedwith
autism) (Muhle 2004) and various comorbid psychiatric disor-
ders including mood disorders (major depressive disorder, bipo-
lar disorder), anxiety disorders (specific phobic disorder, separa-
tion anxiety disorder, social phobia, generalized anxiety disorder,
obsessive compulsive disorder) and disruptive disorders (atten-
tion-deficit hyperactivity disorder, oppositional defiant disorder)
(Leyfer 2006), which render it difficult to be sure about effective-
ness of therapies. The problems andmanifestations of autism spec-
trum disorder might change with time along with other develop-
mental abnormalities. It is also likely that outcomes of treatment
will depend on timing of therapy in relation to age and onset or
progression of problems.
Description of the intervention
Various behavioral interventions for ASD are widely used without
rigorously documented evidence (Bryson 2003, Barlow 2004).
Pharmacological treatments have been, at best, useful adjuncts to
behavioural intervention with improvements in problems such as
attention deficit, sleep disturbance, mood disorder, self-harm or
aggression to others (Posey 2001, Gringras 2000). Many aspects
of ASD are still debatable with elusive and complex etiology and
no agreement on effective therapy exists. Frustrated parents are
therefore eager to explore different forms of complementary and
alternative medicine (CAM) (AAP 2001, Levy 2003; Harrington
2006; Wong 2006; Hanson 2007).
The estimated prevalence of CAM in children with ASD out-
numbers that in the general population, ranging from 31.7% in
Philadelphia (Levy 2003), to as high as 95% inNewYork andNew
Jersey (Harrington 2006). A recent study (Wong 2009) surveyed
a cohort of Hong Kong Chinese with ASD and/or other neurode-
velopmental disabilities. Of these, about 40% of ASD children
reported previous use of CAM, with acupuncture being the most
common form.
Acupuncture is a procedure in which specific body areas, the
meridian points, are pierced with fine needles for therapeutic pur-
poses. It is one of the major modalities of treatment in Traditional
Chinese Medicine. Its use can be traced back more than 2000
years in China (Wu 1996). Reported to be a relatively simple, in-
expensive and safe treatment, acupuncture has been well accepted
by Chinese patients and is widely used in various neurological and
other disorders as an alternative treatment approach (Johansson
1993). Acupuncture is also increasingly practiced in someWestern
countries (NIH 1998).
However, it is worrying that many CAM therapies including
acupuncture that claim to be effective in ASD have not actually
undergone stringent scientific testing. Therefore, as one of most
common forms of CAM, an evidence-based systematic review re-
garding acupuncture for ASD needs to be undertaken.
How the intervention might work
Wellness has been used in the context of alternative medicine
since 1950s (Dunn 1961), which is extensively adopted to mean
a healthy balance of the mind, body and spirit. Wellness pro-
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grams offer alternative medicine techniques to improve wellness,
although whether these techniques actually improve health re-
mains controversial and debatable.
Acupuncture involves complex theories of regulation of five ele-
ments (fire, earth, metal, water, and wood), Yin and Yang, Qi,
blood and body fluids. By stimulating various meridian points,
disharmony and dysregulation of organ systems is corrected to re-
lieve symptoms and restore natural internal homeostasis (Maciocia
1989).
There is no strong evidence to show the correspondence of meridi-
ans or acupoints to any anatomical feature. Themain view believes
a close proximity exists between acupoints and the nervous sys-
tem (Fu 2000). One study (Dung 1984) investigated the anatom-
ical features of acupoints and found that structures in the vicinity
of acupoints exclusively involved nerves; therefore, it is hypoth-
esized that by inserting fine needles into these nerve-innervated
acupoints, a sequence of neurological responses would be elicited.
These reposes can occur locally or close to the site of application (
Jansen 1989), or at a distance,mediatedmainly by sensory neurons
to many structures within the central nervous system (Magnusson
1994). This can lead to activation of pathways affecting various
physiological systems in the brain as well as in the periphery (Sun
2001; Middlekauff 2004; Liu 2004). The effect of acupuncture
had been demonstrated in animal and human studies to be due
to direct neural stimulation, changes in neurotransmitters such as
endorphin, immunological markers or endocrinological signals (
Stux 1998).
Like many CAM forms of treatment, the Traditional Chinese
Medicine (TCM) approach to treating ASD is holistic. The patho-
genesis of ASD according to TCM is ’derangement and insuffi-
ciency of brain and mind’ (Chen 2008). The pathologic involve-
ment is in the brain, relating to the heart, pericardium, liver, spleen
and kidney (Chen 2008). In traditional Chinese acupuncture,
nearly 400 acupoints on the body surface are interrelated to various
functions linked through 14 meridians to various organs or vis-
cera of the human body. By stimulating various meridian points,
acupuncture may be able to correct the disharmony and dysreg-
ulation of organ systems, which might be involved in various di-
mensions of ASD, to relieve symptoms and restore the mind and
body. The scientific basis of how acupuncture could ameliorate
different cognitive and behavioral dimensions of autism has not
been well studied and the mechanisms of how acupuncture works
is likely to be very complex, given the vast number of acupoints
involved in the treatment of this complicated disease.
Why it is important to do this review
Acupuncture is claimed to be effective in treating virtually all dis-
eases; however, it remains uncertain whether the existing evidence
supports the use of acupuncture for patients with autistic spec-
trum disorder.
O B J E C T I V E S
The objectives of this systematic review are to determine the effec-
tiveness and safety of acupuncture therapy in patients with autism
spectrum disorder. We intend to assess whether acupuncture:
1. is effective in reducing social, communication and behavioural
impairments;
2. can improve the quality of life and overall functioning;
3. is associated with any adverse effects.
M E T H O D S
Criteria for considering studies for this review
Types of studies
1. Randomised controlled clinical trials using truly random or
quasi-random allocation of treatment will be included in the re-
view. Quasi-randomisation may involve, for example, alternate al-
location or allocation by birthdate.
2. Studies comparing acupuncture with at least one control group
that uses no treatment, placebo treatment or sham treatment will
be included.
3. Parallel group and crossover designs will be included.
Types of participants
People of any age and both genders with autism spectrum disor-
ders such as autistic disorder or pervasive developmental disorder
diagnosed by standard criteria such as the DSM or ICD criteria.
Diagnosis by assessment tools such as Autism Diagnostic Obser-
vation Scale (ADOS) (Lord 1997), Autism Diagnostic Interview-
Revised (ADI-R) (Lord 1994), theDiagnostic Interview for Social
and Communication Disorders (DISCO) (Wing 1999) and the
3di (Skuse 2004) are also accepted.
Types of interventions
Trials evaluating all forms of acupuncture therapy including acu-
pressure, laser acupuncture or electroacupuncture will be included
in the review regardless of number of times of treatment and length
of treatment period. Either traditional acupuncture in classical
meridian points or contemporary acupuncture in non-meridian or
trigger points will be included regardless of the source or methods
of stimulation (e.g. hand, needle, laser, or electrical stimulation).
The control interventions will be no treatment, placebo acupunc-
ture or sham acupuncture. Placebo acupuncture refers to a nee-
dle attached to the skin surface (not penetrating the skin but at
the same acupoints) (Furlan 2005). Sham acupuncture refers to a
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needle placed in an area close to but not in acupuncture points (
Furlan 2005) or subliminal skin electrostimulation via electrodes
attached to the skin (SCSSS 1999).
Comparisons that will be investigated are listed below:
1. acupuncture only compared to no treatment;
2. acupuncture only compared with placebo or sham treatment;
3. acupuncture in addition to baseline medication or treatment
compared with baseline medication or treatment alone;
4. acupuncture in addition to baseline medication or treatment
compared with placebo or sham treatment in addition to baseline
medication or treatment.
Trials that compared only different forms of acupuncture or com-
paring acupuncturewith other forms of treatmentwill be excluded.
Types of outcome measures
Primary outcomes
Behavioural observations and standardised assessments of autistic
behaviours
Secondary outcomes
1.Communication and linguistic ability by standardised measure-
ments
2. Cognitive functioning by standardised measurements
3. Global functioning measurements
4. Quality of life measurements
5. Adverse effects
As ASD is a spectrum disorder, different parents may have dif-
ferent concerns for their children. However, the dominant aim of
different interventions for ASD is to improve the global functions
via ameliorating various sub-aspects such as behavior, language,
and cognitive function, with the ultimate aim of improving the
quality of life.
Behavioral problems in patients with ASD are myriad and vari-
able. Many behavioral dimensions are usually assessed together
in standardised instruments. Different instruments may subcat-
egorise behavioural disturbances in different ways; therefore be-
havioral problems are not further subcategorised in the protocol,
but some examples of potentially relevant instruments are listed
below.
Examples of behavioral assessment tools adopted for evaluation
of ASD include the Aberrant Behavioral Checklist (ABC) (Aman
1986) , Ritvo-Freeman Real Life Scale (RFRLS) (Freeman 1986)
and theAutismTreatmentEvaluationChecklist (ATEC) (Rimland
ND). In addition, the Parental Stress Index (PSI) (Abidin 1995)
can be used as a measure for parental concern of behavioural dis-
turbances.
Instruments for evaluating communication and linguistic abilities
may include the Reynell Language Developmental scale (RLDS) (
Edwards 1997), the Symbolic Play Test (SPT), (Lowe 1976), and
the Arabic language test for language (Allam 2008).
Instruments for evaluating general cognitive functioning include
the Griffiths Mental Developmental Scale (GMDS) (Griffiths
1996 ) and the Leiter International Performance Scale-Revised
(Leiter-R) (Leiter 1980).
Instruments for evaluating global functioning might include the
Pediatric Evaluation Disability Inventory (PEDI) (Haley 1992) or
the Functional Independence Measure for Children, or ’WeeFIM’
(Msall 1994).
Instruments for evaluating quality of life may include for example
the WHOQOL-BREF (WHO 1993), which has been used in
some ASD studies (Shu 2009, Mugno 2007).
The most common adverse events of acupuncture are needle pain,
tiredness, and bleeding (Ernst 2001). Feeling of faintness and syn-
cope were uncommon and pneumothorax is rare (Ernst 2001).
Patients with ASD may experience adverse effects of acupuncture
but may be unable to convey relevant information to their parents
or the researchers due to impairment of communication. Gener-
ally, the side effects of acupuncture should be monitored in the
studies. The prevalence of various adverse effects will be reported
and analysed in the current systematic review if sufficient data are
identified.
Search methods for identification of studies
Electronic searches
We will search the Cochrane Central Register of Controlled Trials
(CENTRAL) (latest issue), MEDLINE, EMBASE, PsycINFO,
Dissertation Abstracts International, CINAHL, AMED (the Al-
lied and Complementary Medicine Database), and TCMLARS
(Traditional Chinese Medical Literature Analysis and Retrieval
System) which is a database of Chinese biomedical research lit-
erature. We will also search relevant clinical trials and research
databases including the National Center for Complementary and
AlternativeMedicine, theNational Institute ofHealthClinical Tri-
als Database, the Chinese Acupuncture Trials Register and the Tri-
als Register of the Cochrane Complementary Medicine Field. The
China Journals Full-text Database, China Master Theses Full-text
Database, China Doctor Dissertations Full-text Database, China
Proceeding of Conference Database, and Index to Chinese peri-
odical literature on WWW (tw) will also be searched.
The following search strategy, using a combination of controlled
vocabulary and text word terms, will be used for MEDLINE, and
will be modified to suit other databases:
To search for autism spectrum disorder, we will use the following
strategy:
1. expCHILD-DEVELOPMENT-DISORDERS-PERVASIVE/
2. COMMUNICATION/
3. AUTIS$.tw
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4. PDD .tw
5. PERVASIVE DEVELOPMENTAL DISORDER$.tw
6. LANGUAGE adj/3 DELAY
7. COMMUNICAT$
8. SPEECH adj/3 DISORDER$
9. CHILDHOOD SCHIZOPHRENIA
10. KANNER$
11. ASPERG$
12. or/1-11
To search for acupuncture, we use the following strategy:
1. exp acupuncture therapy/
2. acupunc$.tw
3. acupress$.tw
4. electroacupunc$.tw
5. meridian$.tw
6. acupoint$.tw
7. or/1-6
Finally, we will combine the results of the above two strategies
with the highly sensitive search strategy for randomised controlled
trials as described in theCochrane Handbook for Systematic Reviews
of Interventions (Higgins 2008).
The Chinese translation of autism is equivalent to “Self Shut-Off
Syndrome” in Hong Kong and Taiwan while in Mainland China,
it is known as the “Lonely Syndrome”.
The following Chinese key words (either simplified or complex
characters) were also used for retrieving relevant Chinese database:
“ZiBiZheng”(Self Shut-off Syndrome), GuDuZheng (lonely
Syndrome), “ZhenJiu” (Acupuncture). “ZhenCi” (Acupunc-
ture), “DianZhen” (Electro-acupuncture), “ZhenYa” (Acupres-
sure), “ErZhen” (Ear Acupuncture), “TiZhen” (Body acupunc-
ture), “SheZhen” (Tongue acupuncture), “TouPiZhen” (Scalp
acupuncture) and “XueWei” (acupoint).
Searching other resources
The reference lists of all relevant papers will be searched for further
studies.
The process of searching many different sources may bring to light
direct or indirect references to unpublished studies. We will seek
to obtain copies of such unpublished material. In addition, we
will contact colleagues and experts in the field to ascertain any
unpublished or ongoing studies.
There is no language restriction in the search and inclusion of
studies.
Data collection and analysis
Selection of studies
Two review authors will independently review titles and abstracts
of references retrieved from the searches and will select all poten-
tially relevant studies. Copies of these articles will be obtained,
and reviewed independently by the same reviewers against the in-
clusion criteria of the study. Reviewers will not be blinded to the
names of the authors, institutions or journal of publication. The
review authors will then extract data from included trials and as-
sess trial quality independently. All disagreements will be resolved
by consensus.
Data extraction and management
The following data will be extracted:
(1) Study methods
a. Design (e.g. parallel or crossover design).
b. Randomisation method (including list generation)
c. Method of allocation concealment
d. Blinding method
e. Stratification factors
(2) Participants
a. Inclusion/exclusion criteria
b. Number (total/per group)
c. Age and sex distribution
d. Specific diagnosis/diagnostic subtypes
e. Co-morbidities
f. Duration of disorder
g. Previous treatments
(3) Intervention and control
a. Type of acupuncture
b. Details of treatment regime including duration of treatment
c. Type of control
d. Details of control treatment including drug dosage
e. Details of co-interventions
f. Washout period in cross-over design
(4) Follow-up data
a. Duration of follow-up
b. Dates of treatment withdrawal and reasons for treatment with-
drawal
c. Withdrawal rates
(5) Outcome data as described above
(6) Analysis data
a. Methods of analysis (intention-to-treat/per-protocol analysis)
b. Comparability of groups at baseline (yes/no)
c. Statistical techniques
Data will be entered on to RevMan 5.0 by one reviewer (Chen
WX) and then checked by the second reviewer (Cheuk DKL).
Assessment of risk of bias in included studies
Risk of bias will be assessed independently by two review authors
according to the Cochrane Collaboration Handbook (Higgins
2008). Review authors will independently assess the risk of bias
within each included study based on the following six domains
with ratings of ’Yes’ (low risk of bias); ’No’ (high risk of bias) and
’Unclear’ (uncertain risk of bias):
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Sequence generation
Description: the method used to generate the allocation sequence
will be described in detail so as to assess whether it should have
produced comparable groups; review authors’ judgment: was the
allocation concealment sequence adequately generated?
Ratings: ’Yes’ (low risk of bias); ’No’ (high risk of bias) and ’Unclear’
(uncertain risk of bias)
Allocation concealment
Description: the method used to conceal allocation sequence will
be described in sufficient detail to assess whether intervention
schedules could have been foreseen in advance of, or during, re-
cruitment; review authors’ judgment: was allocation adequately
concealed?
Ratings: ’Yes’ (low risk of bias); ’No’ (high risk of bias) and ’Unclear’
(uncertain risk of bias)
Blinding
Description: any measures used to blind participants, personnel
and outcome assessors will be described so as to assess knowledge
of any group as to which intervention a given participant might
have received; review authors’ judgment: was knowledge of the
allocated intervention adequately prevented during the study?
Ratings: ’Yes’ (low risk of bias); ’No’ (high risk of bias) and ’Unclear’
(uncertain risk of bias)
Incomplete outcome data
Description: If studies do not report intention-to-treat analyses,
attempts will be made to obtain missing data by contacting the
study authors. Data on attrition and exclusions will be extracted
and reported as well the numbers involved (compared with to-
tal randomized), reasons for attrition/exclusion where reported or
obtained from investigators, and any re-inclusions in analyses per-
formed by review authors; review authors’ judgment: were incom-
plete data dealt with adequately by the reviewers? (See also ’Han-
dling missing data’, below).
Ratings: ’Yes’ (low risk of bias); ’No’ (high risk of bias) and ’Unclear’
(uncertain risk of bias)
Selective outcome reporting
Description: attempts will bemade to assess the possibility of selec-
tive outcome reporting by investigators by contacting authors for
any non-reported findings; review authors’ judgment: are reports
of the study free of suggestion of selective outcome reporting?
Ratings: ’Yes’ (low risk of bias); ’No’ (high risk of bias) and ’Unclear’
(uncertain risk of bias)
Other sources of bias
We will assess if the study was apparently free of other problems
that could put it at a high risk of bias.
Measures of treatment effect
Binary outcomes
Relative risk with 95% confidence intervals (CI) will be used for
binary outcomes.
Continuous outcomes
Weighted mean difference with 95% CI will be used for continu-
ous outcomes. If studies use the same rating scales, weighted mean
differences (WMD) and 95% confidence intervals will be calcu-
lated. If studies use different scales to measure the same outcomes,
the standardized mean difference (SMD) will be calculated with
95% confidence intervals.
All analyses will include all participants in the treatment groups
to which they were allocated if data are available.
Unit of analysis issues
There may be unit of analysis issues when cross-over trials are
included in themeta-analysis. The cross-over trials will be assessed
to see whether: (i) the cross-over design is suitable; (ii) there is a
carry-over effect; (iii) only first perioddata are available; (iv) correct
analysis has been performed; and (v) comparability of results with
those from parallel-group trials. Where appropriate, the results of
the cross-over trials will be combined with results of parallel-group
trials.
When conducting a meta-analysis combining the results of cross-
over trials, we will use the inverse variance methods recommended
by Elbourne (Elbourne 2002).Where data presented from a cross-
over trial is restricted (and more information is not available from
the original investigators) we will use the presented data within
the first phase only, up to the point of cross-over.
Dealing with missing data
Handling missing data: In the first instance, authors will be con-
tacted to supply data missing from included studies. Missing data
and drop-outs/attrition will be assessed for each included study,
and the extent to which the results/conclusions of the review could
be altered by the missing data will be assessed and discussed. If less
than 70% of patients allocated to the treatments are not reported
on at the end of the trial, for a particular outcome, those data will
not be used as they will be considered to be too prone to bias.
Differential drop-outs in the intervention group will also be noted
and reasons assessed as these can potentially bias the study results.
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Assessment of heterogeneity
Investigation of heterogeneity: Clinical heterogeneity will be as-
sessed by comparing the distribution of important participant fac-
tors between trials (age, gender, specific diagnosis/diagnostic sub-
types, duration of disorder, associated neuropsychiatric diseases),
and trial factors (randomisation concealment, blinding, losses to
follow-up, treatment type, co-interventions). Statistical hetero-
geneity will be assessed by examining (Higgins 2002), a quantity
which describes approximately the proportion of variation in point
estimates that is due to heterogeneity rather that sampling error.
In addition, chi-squared test of homogeneity will be employed to
determine the strength of evidence that heterogeneity is genuine.
Assessment of reporting biases
Assessment of bias: Funnel plots (effect size against standard error)
will be drawn if sufficient studies are found. Asymmetry could
be due to publication bias, but can also be due to a relationship
between trial size and effect size. In the event that a relationship
is found, clinical diversity of the studies will be examined (Egger
1997).
Data synthesis
Where the interventions are the same or similar enough, we plan to
synthesize results in ameta-analysis if there is no important clinical
heterogeneity. Both the fixed-effect model and the random-effect
model will be used in the meta-analysis.
Subgroup analysis and investigation of heterogeneity
Sub-group analysis: Analysis of a number of sub-groups can lead
to misleading conclusions (Higgins 2008), and are best kept to a
minimum. If data permit, we will conduct sub-group analyses for
different age groups, diagnostic subtypes or severity of disease.
Sensitivity analysis
Sensitivity analyseswill be conducted to assess the impact of studies
with different levels of risk of bias
in particular, those using adequate methods of allocation conceal-
ment such as sealed opaque envelopes or telephone randomisation
versus those using methods which are inadequate or unclear.
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